XFOR

NASD X4 Pharmaceuticals, Inc.
Sep 29, 2026 · 4:13 AM ET EOD Market Closed

$3.02 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.02, $0.02 below the day’s high of $3.04

YTD change
-24.62%
vs 20-day SMA
-16.42%
vs 200-day SMA
-23.19%

Price ranges

Previous day
$2.81 $3.04
open $2.99 close $3.02
+$0.02 (+0.84%)
Today
$2.81 $3.04
$3.02
Past week
$2.96 $3.58
from $3.58 now $3.02
-$0.57 (-15.78%)
Past month
$2.96 $4.23
from $4.23 now $3.02
-$1.22 (-28.72%)
This year
$2.81 $4.83
from $4.00 now $3.02
-$0.99 (-24.62%)

Price & Performance

-0.98 (-24.44%) / 6M

$2.87$3.51$4.16$4.80Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.6% away from all-time highs of $717.90
  • XFOR is down 25% since the beginning of the year
  • XFOR is down 13% over the past 12 months
  • XFOR is down 29% over the past 1 month
  • 7% of all XFOR investors are betting against XFOR

XFOR reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -10.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.13
Earnings momentum +28.6% Quarterly EPS growth
Quarterly change +28.6%

Valuation

P/E ratio 150.00
Enterprise value $249.0M
Beta 0.28

Balance sheet & scale

IncomeN/A
Revenue$15.8M
Cash$208.5M
Debt$77.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $298.9M

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $418.13 +0.85%
MRNA Moderna, Inc. $197.28 -0.80%
RVMD Revolution Medicines, Inc. $201.74 -1.58%
ROIV Roivant Sciences Ltd. $36.98 +3.30%
BNTX BioNTech SE Sponsored ADR $99.08 +0.57%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.